Skip to main content
OpenTrials

Clinical trial condition

Recurrence

Explore clinical trials studying Recurrence. Study availability and eligibility vary by location and protocol.

2,310 public trials 520 recruiting studies
Refine in advanced search Browse all conditions

Recurrence trial results

Recruiting

Ziftomenib in Combination With Chemotherapy for Children With Relapsed/Refractory Acute Leukemia

NCT06376162

Conditions
Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, +4 more
Locations
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • Children's Hospital Colorado Aurora, Colorado, United States
  • Children's Healthcare of Atlanta Atlanta, Georgia, United States
  • Ann & Robert H. Lurie Children's Hospital of Chicago Chicago, Illinois, United States
View all 20 locations
View Trial Details
Recruiting

A Study of TLN-254 in Participants With Relapsed or Refractory T-cell Lymphoma

NCT06733441

Conditions
Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +13 more
Locations
  • Stanford Cancer Institute Stanford, California, United States
  • Washington University School of Medicine St Louis, Missouri, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
  • Sarah Cannon Research Institute Nashville, Tennessee, United States
View Trial Details
Recruiting

Chemoablation Or Bladder Resection With Adjuvant Chemotherapy in Recurrent Non-Muscle Invasive Bladder Cancer

NCT06781879

Conditions
Carcinoma, Disease Attributes, Female Urogenital Diseases, +17 more
Locations
  • Aalborg University Hospital Aalborg, Denmark
  • Aarhus University Hospital Aarhus N, Denmark
  • Herlev and Gentofte Hospital Herlev, Denmark
  • Zealand University Hospital, Roskilde Roskilde, Denmark
View Trial Details
Recruiting

A Study of AC676 for the Treatment of Relapsed/Refractory B-Cell Malignancies

NCT05780034

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +30 more
Locations
  • Colorado Blood Cancer Institute Denver, Colorado, United States
  • Florida Cancer Specialists Sarasota, Florida, United States
  • University of North Carolina Chapel Hill, North Carolina, United States
  • University Hospitals Cleveland Medical Center Cleveland, Ohio, United States
View Trial Details
Recruiting

MEN1703 (SEL24) to Treat Relapsed or Refractory Aggressive B-cell Non-Hodgkin Lymphoma (JASPIS-01)

NCT06534437

Conditions
Aberrant Motor Behavior in Dementia, Aggression, Behavior, +16 more
Locations
  • Centre Hospitalier Le Mans Le Mans, France
  • CHU de Lille - Hôpital Claude Huriez Lille, France
  • CHU de Limoges - CHU Dupuytren Limoges, France
  • Hospices Civils De Lyon - Hôpital Lyon Sud Lyon, France
View all 36 locations
View Trial Details
Recruiting

A Study of BL-M11D1 in Patients With Relapsed/Refractory Acute Myeloid Leukemia

NCT05924750

Conditions
Disease Attributes, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
Locations
  • Anhui Provincial Hospital Hefei, Anhui, China
  • Beijing Hospital Beijing, Beijing Municipality, China
  • Institute of Hematology, the First Hospital of Harbin Haerbin, Heilongjiang, China
  • Shengjing Hospital of China Medical University Shenyang, Liaoning, China
View Trial Details

Related conditions